{
    "medicine_id": "83c3ce4f4903c6b22193474faa155fd607e82ea8",
    "platform_id": "DB04971",
    "metadata": {
        "name": "Potiga 50 mg 1 Tablet film coated",
        "composition": "50 mg 1 Reglitazar",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of diabetes mellitus type 1 and 2",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Reglixane shows a hypoglycemic effect and also a stronger triglyceride lowering effect than the thiazolidine 2 4 diones In preclinical studies reglixane has been shown to prevent several diabetic complications such as cataract nephropathy and neuropathy",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}